| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -43.52M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CABA returned +93.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +42.9% |
| 1 year | +93.2% |
| 5 years | -69.3% |
| All-time high | $22.88 (Feb 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CABA would be worth today ›No. Cabaletta Bio, Inc. has not paid a dividend in the past 12 months.
Cabaletta Bio, Inc. stock trades on NASDAQ under the ticker symbol CABA.
Cabaletta Bio, Inc. is part of the Healthcare sector.
Cabaletta Bio, Inc. has a market cap of 530.68M USD, based on the latest quote.
Cabaletta Bio, Inc. is expected to report earnings around Nov 16, 2026. That date is an estimate and has not been confirmed by the company.
